Video from RSNA 2019: Get ready for changes to radiology billing in 2020

Dec 3, 2019
Latest in Clinical News
Lungs Body
4DMedical inks major distribution agreement for CT:VQ
December 12, 2025
Lung Cancer
What causes lung cancers to be missed on screening?
December 12, 2025
2025 12 12 Fapi Breast Cancer Thumbnail
Early PET/CT feasible in women with suspected breast cancer
December 12, 2025
Doctor Patient Consult Tablet
Study highlights risk-based breast cancer screening; ACR responds
December 12, 2025
Related Stories
2019 12 01 17 59 7967 Rsna 2019 Sign 400
CT
AI spots heart disease on CT lung screening exams
2019 12 02 18 50 3160 Wengler Mri Depression Rsna 400
MRI
MRI illuminates causes of depression
2019 12 01 20 34 0306 Mri Corpus Callosum Concussion Rsna 400
MRI
MRI finds communication breakdown after concussion
2019 11 27 22 03 3360 2019 12 03 Scooter Fracture 20191127222504
CT
Researchers present perils of e-scootering at RSNA 2019
More in Clinical News
4DMedical inks major distribution agreement for CT:VQ
By AuntMinnie.com staff writers
Academic medical centers will serve as critical reference points for clinical validation, physician education, and broader market adoption, according to firm.
December 12, 2025
Lungs Body
What causes lung cancers to be missed on screening?
By Kate Madden Yee
Incomplete smoking history documentation appears to be one of the reasons.
December 12, 2025
Lung Cancer
Early PET/CT feasible in women with suspected breast cancer
By Will Morton
Early imaging is not only more patient-friendly but also has the potential to simplify clinical workflows.
December 12, 2025
2025 12 12 Fapi Breast Cancer Thumbnail
Study highlights risk-based breast cancer screening; ACR responds
By Amerigo Allegretto
A study showing the potential benefits of risk-based breast cancer screening has drawn criticism from the ACR.
December 12, 2025
Doctor Patient Consult Tablet
Is AI ready for autonomous reads of chest x-rays?
By Liz Carey
A debate at RSNA 2025 reviewed the current use of autonomous AI for chest radiographs and assessed future opportunities.
December 11, 2025
At RSNA 2025, thoracic radiologists debated using autonomous AI for chest radiograph interpretation. They also fielded many audience questions and comments as well.
Lung cancer rates low on chest CT after incidental neck imaging findings
By Kate Madden Yee
The results could indicate that follow-up chest CT may not be necessary in this situation.
December 11, 2025
Lung Cancer
Canon showcases CT innovations at RSNA 2025
By AuntMinnie.com staff writers
Canon exhibited two work-in-progress technologies in a research-focused section of its booth.
December 10, 2025
Canon
Adding AI to MRI improves return to play classification frameworks
By Kate Madden Yee
Predicting when athletes can safely return to play after an injury is key.
December 10, 2025
Football Players Scrimmage
Marathon training does not have long-term negative effects on heart
By Amerigo Allegretto
Echocardiography shows that endurance training by marathon runners does not have long-term negative effects on the heart.
December 10, 2025
Runner Street Thumbnail Adobe Augustas Cetkauskas
Telix and Varian enter research collaboration
By AuntMinnie.com staff writers
The two firms will identify opportunities to use Telix’s prostate cancer PET imaging agents in selecting patients for radiation therapy.
December 10, 2025
Acquisitions
Imaging Biometrics and GE HealthCare expand agreement
By AuntMinnie.com staff writers
GE HealthCare will now distribute Imaging Biometrics’ Fractional Tumor Burden (FTB) Express and QSMetric software applications.
December 10, 2025
Ai Handshake
Phase I trial reveals the potential of a new PSMA-PET tracer
By Will Morton
The radiotracer detected more lesions in men with metastatic disease than F-18 piflufolastat.
December 9, 2025
Scans in a 73-year-old man with biochemically recurrent prostate cancer (prostate-specific antigen level of 0.5 ng/mL) who underwent PET/CT with 9.4 mCi of F-18 piflufolastat and a second PET/CT examination with 8.1 mCi of copper 61-NODAGA (1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid)–prostate-specific membrane antigen for imaging and therapy (Cu-61 PSMA I&T) 24 days apart, with no intervening therapy. Maximum intensity projection (MIP) images obtained (A) 1 hour after F-18 piflufolastat administration and (B) 1, (C) 2, and (D) 4 hours after Cu-61 PSMA I&T administration are shown. Physiologic uptake is seen in the lacrimal glands, salivary glands, liver, spleen, kidneys, ureters, and bladder. Pathologic uptake in pelvic nodal metastases is labeled with arrows. The F-18 piflufolastat PET/CT MIP image reveals two avid pelvic nodal metastases (arrows). Cu-61 PSMA I&T PET/CT scans demonstrate three avid pelvic nodal metastases on 1-hour and 2-hour images (arrows); five avid pelvic nodal metastases were suspected on the 4-hour image (arrows).
Page 1 of 3709
Next Page